02616.HK
CStone Pharmaceuticals
HKSE · Healthcare · Biotechnology · CN
HKD 6.19
+0.16%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- 2.22x
- P/E 2028E
- 32.53x
- P/S forward
- 6.77x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 5.70x
- Price / sales
- 12.27x
- Price / cash flow
- -14.48x
Enterprise value
- Enterprise value
- HKD 7.2B
- EV / sales
- 10.27x
- EV / EBITDA
- -11.01x
- EV / EBIT
- -9.80x
- Market cap
- HKD 8.6B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026